Hi, I wanted to let you know how much better I feel since I have been using the Hyaluronic Acid, Vitamin E and Aloe vaginal cream. It really is like a miracle. A great product that has increased my comfort and has allowed me to put my attention on other parts of my life. Thanks – Mary M.
Non-Hormonal (No Estrogen) Treatment Option for Vaginal Atrophy
A NON-HORMONAL APPROACH IS IDEAL FOR PATIENTS WITH:
Estrogen Positive Cancer
Fearful of Hormones
Family History of Cancer
As women enter the menopausal age and their hormone levels drop, symptoms of menopause become exacerbated. With this hormone loss, the vaginal epithelium becomes atrophic and physiological lubrication is reduced. This can lead to physical discomforts such as vaginal dryness, irritation, itching, burning, dyspareunia; all which can lead to decreased libido, causing sexual distress both to the patient and her partner.
Unlike current lubricant therapies which are short term solutions and don’t actually restore the vaginal tissue, our solution for helping women with vaginal dryness, atrophy and loss of elasticity is a unique approach of non-estrogen vaginal restoration:
HYALURONIC ACID VAGINAL CREAM – 30 gm
Sig: 1 gm HS X 14 to 21 days then 1-3 times per week
Hyaluronic acid helps to form an extracellular water film which moisturizes the skin, maintaining a water balance that aids in skin elasticity. It also facilitates the healing process and tissue regeneration. Vitamin E, which has antioxidant properties, is added to act as an anti-inflammatory and healing agent. And Vitamin A increases the function of the immune local cells and the epithelium of the vagina. We also add aloe to heal and provide restoration.
SEE ALSO: Saliva Hormone Testing
A DOCUMENTED STUDY
Constantino and Guaraldi’s 2008 study utilized a vaginal suppository containing hyaluronic acid sodium salt 5 mg, vitamin E acetate 1 mg, and vitamin A palmitate 1 mg. Dosing was an intravaginal suppository used every night for 14 nights, then tapering to every other night for 14 nights. The study assessed efficacy of the study medication in the areas of burning, itching, dyspareunia, inflammation and irritation. Results showed symptoms were resolved to either mild or absent at the end of four weeks.